Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of central nervous system (CNS) active compounds. Its structure supports the creation of selective receptor modulators, including antipsychotics and antidepressants. The presence of a fluorinated benzyl group enhances binding affinity to certain neurotransmitter receptors, improving potency and metabolic stability. Commonly utilized in research settings for designing novel piperazine-based drugs with improved pharmacokinetic profiles.